FDAnews Drug Daily Bulletin

PROTAGEN AG CLOSES SECOND ROUND OF FINANCING WITH OLD AND NEW INVESTORS

May 9, 2006
A A

The MIG AG Funds 1 and 3 in Munich are investing into Protagen AG. In cooperation with the co-investor S-Venture Capital Dortmund GmbH, EUR 3,3 Million will be invested into Protagen AG. Protagen AG has successfully switched from a fee-for-service company to a product company. CCN Matthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=593245)